Literature DB >> 19904612

Acromegaly with negative pituitary MRI and no evidence of ectopic source: the role of transphenoidal pituitary exploration?

Sameera Daud1, Amir H Hamrahian, Robert J Weil, Marwan Hamaty, Richard A Prayson, Leann Olansky.   

Abstract

Growth hormone (GH) producing adenomas of the pituitary gland are usually macroadenomas (>10 mm in size). Often these adenomas are locally invasive by the time of diagnosis. Acromegaly secondary to a very small pituitary microadenoma not visualized on pituitary magnetic resonance (MR) imaging is rare. We report a patient with acromegaly and an unremarkable pituitary MR imaging who had negative work up for ectopic growth hormone-releasing hormone (GHRH) or GH secreting tumors. Transsphenoidal pituitary exploration revealed a pituitary adenoma located on the left side of the sella against the medial wall of the cavernous sinus extending posteriorly along the floor of the sella all the way to the right side. The acromegaly was treated with resection of the pituitary adenoma and normalization of serum insulin-like growth factor 1 (IGF-1) and GH levels. In a patient with acromegaly and unremarkable pituitary MR imaging, with no evidence of ectopic GH and GHRH production, transsphenoidal pituitary exploration is a reasonable approach and may result in clinical improvement and biochemical cure in the hand of experienced surgeon. This approach may avoid long term medical treatment with its associated cost.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 19904612     DOI: 10.1007/s11102-009-0205-z

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  20 in total

1.  Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease.

Authors:  Jay Jagannathan; Rene Smith; Hetty L DeVroom; Alexander O Vortmeyer; Constantine A Stratakis; Lynnette K Nieman; Edward H Oldfield
Journal:  J Neurosurg       Date:  2009-09       Impact factor: 5.115

2.  Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results.

Authors:  A Abosch; J B Tyrrell; K R Lamborn; L T Hannegan; C B Applebury; C B Wilson
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

3.  Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors.

Authors:  Nicholas Patronas; Nail Bulakbasi; Constantine A Stratakis; Antony Lafferty; Edward H Oldfield; John Doppman; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

4.  Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.

Authors:  G A Kaltsas; A M Isidori; D Florakis; P J Trainer; C Camacho-Hubner; F Afshar; I Sabin; J P Jenkins; S L Chew; J P Monson; G M Besser; A B Grossman
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

5.  Ectopic adrenocorticotropic hormone syndrome: localization studies in 28 patients.

Authors:  J L Doppman; L Nieman; D L Miller; H I Pass; R Chang; G B Cutler; M Schaaf; G P Chrousos; J A Norton; H A Ziessman
Journal:  Radiology       Date:  1989-07       Impact factor: 11.105

6.  Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assay.

Authors:  A Iranmanesh; B Grisso; J D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  1994-03       Impact factor: 5.958

Review 7.  Guidelines for acromegaly management: an update.

Authors:  S Melmed; A Colao; A Barkan; M Molitch; A B Grossman; D Kleinberg; D Clemmons; P Chanson; E Laws; J Schlechte; M L Vance; K Ho; A Giustina
Journal:  J Clin Endocrinol Metab       Date:  2009-02-10       Impact factor: 5.958

8.  Inferior petrosal sinus sampling in acromegaly.

Authors:  P A Crock; E J Gilford; J K Henderson; J Cummins; A J Calenti; J D Best; F P Alford
Journal:  Aust N Z J Med       Date:  1989-06

9.  Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

Authors:  B Swearingen; F G Barker; L Katznelson; B M Biller; S Grinspoon; A Klibanski; N Moayeri; P M Black; N T Zervas
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

10.  Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.

Authors:  P U Freda; K D Post; J S Powell; S L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

View more
  10 in total

1.  Unusual type of growth hormone-producing pituitary tumor in acromegaly.

Authors:  Satoshi Yamagata; Kazunori Kageyama; Satoru Sakihara; Shozo Yamada; Shinobu Takayasu; Shinji Chikazawa; Naoko Inoshita; Toshiaki Sano; Toshihiro Suda
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

2.  Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population.

Authors:  Pedro Weslley Rosario
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

3.  Acromegaly without imaging evidence of pituitary adenoma.

Authors:  Russell R Lonser; Bogdan A Kindzelski; Gautam U Mehta; John A Jane; Edward H Oldfield
Journal:  J Clin Endocrinol Metab       Date:  2010-07-07       Impact factor: 5.958

4.  Screening for acromegaly by application of a simple questionnaire evaluating the enlargement of extremities in adult patients seen at primary health care units.

Authors:  Pedro Weslley Rosario; Maria Regina Calsolari
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

5.  EMPTY SELLA IN A PATIENT WITH CLINICAL AND BIOCHEMICAL DIAGNOSIS OF ACROMEGALY.

Authors:  N Bestepe; C Aydin; A A Tam; K Ercan; R Ersoy; B Cakir
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

6.  Where is the culprit? A case of acromegaly that defied the management algorithm.

Authors:  Celito A Tamban; Mark Anthony S Sandoval; Frances Lina Lantion-Ang
Journal:  BMJ Case Rep       Date:  2013-01-17

7.  Acromegaly with no pituitary adenoma and no evidence of ectopic source.

Authors:  Deepak Khandelwal; Rajesh Khadgawat; Amar Mukund; Ashish Suri
Journal:  Indian J Endocrinol Metab       Date:  2011-09

8.  Clinical manifestations and diagnosis of acromegaly.

Authors:  Gloria Lugo; Lara Pena; Fernando Cordido
Journal:  Int J Endocrinol       Date:  2012-02-01       Impact factor: 3.257

9.  Clinical experiences and success rates of acromegaly treatment: the single center results of 62 patients.

Authors:  Mehtap Evran; Murat Sert; Tamer Tetiker
Journal:  BMC Endocr Disord       Date:  2014-12-16       Impact factor: 2.763

10.  Prevalence of acromegaly in patients with symptoms of sleep apnea.

Authors:  Gemma Sesmilo; Eugenia Resmini; Marcel Sambo; Concepción Blanco; Fernando Calvo; Fernando Pazos; Pablo Fernández-Catalina; Purificación Martínez de Icaya; Concepción Páramo; Carmen Fajardo; Mónica Marazuela; Cristina Álvarez-Escolá; Juan Jose Díez; Verónica Perea
Journal:  PLoS One       Date:  2017-09-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.